Emergent: FDA approved troubled facility to resume vaccine production | The Hill: Healthcare Policy

The Food and Drug Administration (FDA) granted approval for the troubled Emergent BioSolutions plant to resume production of Johnson & Johnson vaccine doses, the company announced on Thursday. The reopening of the Baltimore factory, which&...